NCCN Task Force report: Positron Emission Tomography (PET)/Computed Tomography (CT) scanning in cancer

Donald A. Podoloff, Ranjana H. Advani, Craig Allred, Al B. Benson, Elizabeth Brown, Harold J. Burstein, Robert W. Carlson, R. Edward Coleman, Myron S. Czuczman, Dominique Delbeke, Stephen B. Edge, David S. Ettinger, Frederic W. Grannis, Bruce E. Hillner, John M. Hoffman, Krystyna Kiel, Ritsuko Komaki, Steven M. Larson, David A. Mankoff, Kenneth E. RosenzweigJohn M. Skibber, Joachim Yahalom, J. Q.Michael Yu, Andrew D. Zelenetz

Research output: Contribution to journalReview articlepeer-review

106 Scopus citations


The use of positron emission tomography (PET) is increasing rapidly in the United States, with the most common use of PET scanning related to oncology. It is especially useful in the staging and management of lymphoma, lung cancer, and colorectal cancer, according to a panel of expert radiologists, surgeons, radiation oncologists, nuclear medicine physicians, medical oncologists, and general internists convened in November 2006 by the National Comprehensive Cancer Network. The Task Force was charged with reviewing existing data and developing clinical recommendations for the use of PET scans in the evaluation and management of breast cancer, colon cancer, non-small cell lung cancer, and lymphoma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, possible future developments, and the role of PET in oncology.

Original languageEnglish
Pages (from-to)S-1-S-22
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Issue numberSUPPL. 1
StatePublished - 2007


  • Breast cancer
  • Colorectal cancer
  • Computed tomography (CT)
  • Diagnosis
  • F-FDG
  • Lung cancer
  • Lymphoma
  • NCCN Clinical Practice Guidelines in Oncology
  • Oncology
  • PET/CT
  • Positron emission tomography (PET)
  • Radiography
  • Standard uptake value
  • Treatment


Dive into the research topics of 'NCCN Task Force report: Positron Emission Tomography (PET)/Computed Tomography (CT) scanning in cancer'. Together they form a unique fingerprint.

Cite this